Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa.
about
Vaccines for preventing influenza in people with cystic fibrosisDuration of intravenous antibiotic therapy in people with cystic fibrosisDuration of intravenous antibiotic therapy in people with cystic fibrosisVaccines for preventing influenza in people with cystic fibrosisDigging through the Obstruction: Insight into the Epithelial Cell Response to Respiratory Virus Infection in Patients with Cystic FibrosisViral infections: a role in the lung disease of cystic fibrosis?Lessons from a French collaborative case-control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy.Genomewide association analysis of respiratory syncytial virus infection in mice.The changing microbial epidemiology in cystic fibrosis.Vaccines for preventing influenza in people with cystic fibrosis.Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis lung.Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures.Differential responses to rhinovirus- and influenza-associated pulmonary exacerbations in patients with cystic fibrosisClinical significance of microbial infection and adaptation in cystic fibrosis.The airway epithelium: soldier in the fight against respiratory virusesAge of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung diseaseImpact of respiratory viral infections on cystic fibrosis.Rhinovirus infection liberates planktonic bacteria from biofilm and increases chemokine responses in cystic fibrosis airway epithelial cells.Bronchiectasis exacerbations: The role of atypical bacteria, respiratory syncytial virus and pulmonary function tests.Mycoplasma pneumoniae and its role as a human pathogen.Infective respiratory exacerbations in young adults with cystic fibrosis: role of viruses and atypical microorganisms.Acute severe deterioration in cystic fibrosis associated with influenza A virus infection.Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa.Respiratory syncytial virus infection enhances Pseudomonas aeruginosa biofilm growth through dysregulation of nutritional immunity.Cystic fibrosis and the war for iron at the host-pathogen battlefrontMicrobiology of airway disease in patients with cystic fibrosis.Hospital versus home treatment of respiratory exacerbations in cystic fibrosisRespiratory-related hospitalizations following prophylaxis in the Canadian registry for palivizumab (2005-2012) compared to other international registriesAgglutinating antibody titers to members of the family Legionellaceae in cystic fibrosis patients as a result of cross-reacting antibodies to Pseudomonas aeruginosaReview of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis.Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity.Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: identification of the prairie epidemic strain.Ten years of viral and non-bacterial serology in adults with cystic fibrosis.Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its managementCystic fibrosis. 2. Lung injury in cystic fibrosis.Does prophylaxis with palivizumab reduce hospitalisation rates for respiratory-syncytial-virus-related infection in cystic fibrosis children less than 2 years of age?Peroxisome proliferator-activated receptor-γ agonists attenuate biofilm formation by Pseudomonas aeruginosa.Duration of intravenous antibiotic therapy in people with cystic fibrosis.The diagnosis and management of respiratory viral infections in cystic fibrosis.Respiratory Viral Infections in Chronic Lung Diseases.
P2860
Q24198036-86D217DE-0C56-4B70-BB51-3532837147B0Q24202855-75FC4E7C-8D6C-4B96-B69B-8A9C81A22E06Q24234667-5A21D9A5-EB81-4E43-8FFA-3C3701CE356FQ24240244-F6DB4E81-0537-4E94-A048-A1D6C24C0293Q28078583-60B0E1F8-01FE-4910-9BFE-B7FA9D5CF92AQ28319242-7B733AB2-D279-4431-B6F0-CB3AED0ABEAEQ30384047-90B3B763-2C88-4DED-A08C-5A058CCD9EFBQ33648868-D722242B-0F11-4A75-A62E-4EEFDC9AE37AQ33825634-CCB537B8-4273-4993-A572-1F4C9CA2E8DAQ33909908-DDF370D3-08C4-4560-959D-91CB4AC49107Q33916434-6E665773-D681-41F7-A529-9DFD2BA07A63Q34118967-A6906973-F799-49D7-9416-FF0A4A1A17FAQ34479158-B801FFDF-1E61-4FAA-8D72-FE0DF4CBC520Q34491552-C86F4B64-FB3D-4007-9738-9F295C6AB640Q34491598-D947B1B9-64F9-474D-AF9F-92FA6BF75665Q34554550-F4FBB1BA-CE88-4BC4-9043-FB381137FDF9Q35125997-4FEF9ADE-C164-4202-B15C-494F8B85EDD9Q35524948-180F1FBD-23ED-46FF-8063-4C6BEB06B1EAQ35751474-35699EBC-245F-4053-9236-056E1111EAEDQ35920629-0854FF3C-005F-4060-B80C-4B69FEC16C9EQ36206157-459546D0-274D-4240-9420-ECF8B3E36456Q36256324-703CCBDE-359F-414A-BC67-4755FE149355Q36520797-FE98E214-B25B-4975-B709-AB47FF229077Q36598940-8FD63782-1244-4B8A-A629-FB2DDB85B4A1Q36598958-0727EF6B-11E4-4F45-88E4-C56F803C8048Q36636914-B3B95E4C-045B-474B-8207-7BEC83266761Q36771389-88F1E9BF-AF02-4BAF-9747-325D27D57A4FQ36989863-14AD2C65-566C-40AA-89D0-8B77841853BFQ37264686-EE3953E4-2CE9-431A-B885-21AAEAC4B223Q37307836-80511C87-1E16-4C62-806F-7848C8EBD59DQ37705435-61D33349-3F95-4CF7-BABA-14D69875ECA5Q37713415-1F52854A-D4E8-4599-A0CE-A51A3F5F13C6Q37860254-D2C5F7AF-D38A-456D-AE56-35646C927E20Q38007627-99AC2130-A2D5-4E44-B241-E11198B49DF0Q38027715-F3443C1A-6CE1-4495-966B-C9546EB55729Q38057771-EFB6D927-901D-4D4F-A2E5-CA2A46A5B130Q38820125-ABAC533E-11BF-4D22-8F39-F7B9AC4DC28CQ38943109-ADDA77FA-0014-4276-B5AF-FD24157419E2Q39108263-98ECE252-5320-41AD-9916-4615736031D7Q39118441-A2CE9A55-9F31-442D-A95F-A2946CF7D381
P2860
Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Respiratory infections in cyst ...... m with Pseudomonas aeruginosa.
@en
Respiratory infections in cyst ...... m with Pseudomonas aeruginosa.
@nl
type
label
Respiratory infections in cyst ...... m with Pseudomonas aeruginosa.
@en
Respiratory infections in cyst ...... m with Pseudomonas aeruginosa.
@nl
prefLabel
Respiratory infections in cyst ...... m with Pseudomonas aeruginosa.
@en
Respiratory infections in cyst ...... m with Pseudomonas aeruginosa.
@nl
P2093
P921
P1476
Respiratory infections in cyst ...... m with Pseudomonas aeruginosa.
@en
P2093
P304
P356
10.1111/J.1651-2227.1981.TB05757.X
P577
1981-09-01T00:00:00Z